Little joys for everyday · Free shipping over $75
Login Register
iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective
iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective
iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective
iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective
iv glutathione and cancer

iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective

SKU: 31355070473

4.1
USD27.50 USD51.50

Pay in 4 interest-free payments of $6.88 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 31 - Nov 5

Description

As a molecular probe to study copper transport, binding, and homeostasis in biological systems

iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective

Nitzsche F, Mller C, Lukomska B, Jolkkonen J, Deten A, Boltze J

iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective

There is a required consult that will go towards price of product you are clinically prescribed

iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective

1998;275:C323C326

iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective

[DOI] [PubMed] [Google Scholar] Benlloch M, Ortega A, Ferrer P, Segarra R, Obrador E, Asensi M, Carretero J, Estrela JM

iv glutathione and cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Self-Adaptive Single-Atom Catalyst Boosting Selective
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

QK041
QK041

US$ 24.96

4.1 (25 reviews)

IGF-1LR3
IGF-1LR3

US$ 28.86

4.0 (17 reviews)

IGF-1 LR3
IGF-1 LR3

US$ 27.19

5.0 (22 reviews)

recommand products